A Study to Determine the Correlation Between HbA1c and Lipid Profile in Patients with Type 2 Diabetes Mellitus
International Journal of Pharmaceutical Quality Assurance · 31.05.2026 · 17 (05)
DOI: 10.25258/ijpqa.17.5.44 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 31.05.2026. Verfasst von Zarin Jalal und 3 weiteren Autor:innen.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Type 2 diabetes mellitus (T2DM) is frequently associated with dyslipidemia, which substantially increases the risk of cardiovascular complications. Glycated hemoglobin (HbA1c) reflects long-term glycemic control and may serve as an indicator of lipid abnormalities.
Aim
To determine the correlation between HbA1c and lipid profile parameters in patients with T2DM. Methodology: A hospital-based cross-sectional study was conducted among 100 patients with T2DM aged 4060 years at a tertiary care center in Bihar, India. Demographic and clinical data were recorded using a pre-designed proforma. Fasting blood sugar (FBS), post-prandial blood sugar (PPBS), HbA1c, and lipid profile parameters including total cholesterol (TC), triglycerides (TG), high-density lipoprotein (HDL), low-density lipoprotein (LDL), and very low-density lipoprotein (VLDL) were measured using standard biochemical methods. Pearson's correlation analysis was performed to assess the association between HbA1c and lipid profile parameters, with p < 0.05 considered statistically significant.
Results
The mean age of the participants was 52.46 ± 6.18 years, and 58.0% were male. The mean HbA1c level was 8.14 ± 1.21%, indicating poor glycemic control. The study population demonstrated an atherogenic lipid profile, with mean TC, TG, LDL, HDL, and VLDL levels of 199.58 ± 34.16 mg/dL, 179.60 ± 46.22 mg/dL, 124.34 ± 29.15 mg/dL, 38.89 ± 6.84 mg/dL, and 35.92 ± 9.24 mg/dL, respectively. HbA1c showed significant positive correlations with TC (r = 0.48, p < 0.001), TG (r = 0.55, p < 0.001), LDL (r = 0.51, p < 0.001), and VLDL (r = 0.44, p < 0.001), while a significant inverse correlation was observed with HDL (r = −0.39, p < 0.001). Lipid abnormalities progressively worsened with increasing HbA1c levels.
Conclusion
Poor glycemic control is strongly associated with an atherogenic lipid profile in patients with T2DM. HbA1c may serve as a useful surrogate marker for identifying dyslipidemia and assessing cardiovascular risk in this population.
Zitieren
APA
Jalal, Z., Singh, D., Kumar, S., & Kumar, V. (2026). A Study to Determine the Correlation Between HbA1c and Lipid Profile in Patients with Type 2 Diabetes Mellitus. International Journal of Pharmaceutical Quality Assurance, 17(05). https://doi.org/10.25258/ijpqa.17.5.44
Vancouver
Jalal Z, Singh D, Kumar S, Kumar V. A Study to Determine the Correlation Between HbA1c and Lipid Profile in Patients with Type 2 Diabetes Mellitus. International Journal of Pharmaceutical Quality Assurance. 2026;17(05). doi:10.25258/ijpqa.17.5.44
BibTeX
@article{Jalal2026,
author = {Jalal, Zarin and Singh, Dipali and Kumar, Sanjay and Kumar, Vijay},
title = {A Study to Determine the Correlation Between HbA1c and Lipid Profile in Patients with Type 2 Diabetes Mellitus},
journal = {International Journal of Pharmaceutical Quality Assurance},
year = {2026},
volume = {17},
number = {05},
doi = {10.25258/ijpqa.17.5.44}
}
EUVIMED